Cherry Bonkers is a modern hybrid-indica cultivar derived from Cherry Tahoe. As a versatile genetic project, it has proven its utility in breeding programs, serving as the parent stock for notable offspring including Cherry Bonkers F2, Death By Cherries, and Fight Milk. The strain requires a moderate level of cultivation expertise and performs well in both indoor and outdoor environments. Growers can expect a high yield from this variety, which reaches maturity after a 60-day flowering period.

The sensory profile of Cherry Bonkers is defined by a complex chemical composition, led by a dominant concentration of terpinolene, followed closely by myrcene, caryophyllene, and humulene. This profile continues with notes of bisabolol, limonene, beta-pinene, and nerolidol, while rounding out with pinene, linalool, caryophyllene-oxide, camphene, p-cymene, and ocimene. This diverse range of constituents creates a distinct aromatic expression that reflects the interaction between these primary, secondary, and tertiary terpenes.

This THC-dominant hybrid is characterized by effects that are primarily focused on helping the user feel relaxed, calm, and focused. These qualities make Cherry Bonkers particularly suitable for addressing concerns related to pain, stress, and sleep. Its established genetic influence is evident in its consistent performance as a foundational strain for subsequent hybrid development, maintaining its status as a reliable choice for those seeking specific therapeutic outcomes and targeted cultivation results.